NEW YORK (GenomeWeb News) – Illumina said today that it has entered into a three-year supply agreement with Natera, under which Natera will run its noninvasive prenatal test Panorama on Illumina's HiSeq 2500 and use the associated Illumina consumables.

"This deal enables a major expansion of Natera's laboratory capacity to support the fast-growing demand for our Panorama test," Natera CEO Matthew Rabinowitz said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.